Bariş Boyraz

964 total citations
27 papers, 619 citations indexed

About

Bariş Boyraz is a scholar working on Cancer Research, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Bariş Boyraz has authored 27 papers receiving a total of 619 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cancer Research, 7 papers in Molecular Biology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Bariş Boyraz's work include Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Bariş Boyraz is often cited by papers focused on Cancer Genomics and Diagnostics (5 papers), Genetic factors in colorectal cancer (4 papers) and Ovarian cancer diagnosis and treatment (4 papers). Bariş Boyraz collaborates with scholars based in United States, Türkiye and Israel. Bariş Boyraz's co-authors include Suneet Agarwal, Patrick Cahan, Albert Tai, Peter M. Sadow, Dora Dias‐Santagata, Vânia Nosé, Inga Hofmann, Eva C. Guinan, William C. Faquin and Alexander Farahani and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Investigation and Nature Genetics.

In The Last Decade

Bariş Boyraz

24 papers receiving 610 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bariş Boyraz United States 12 277 134 116 84 80 27 619
K. W. Schmid Germany 15 212 0.8× 235 1.8× 84 0.7× 92 1.1× 104 1.3× 36 692
Ana Pestana Portugal 14 197 0.7× 98 0.7× 74 0.6× 176 2.1× 47 0.6× 26 469
Yevgeniya Kushchayeva United States 14 107 0.4× 162 1.2× 39 0.3× 246 2.9× 58 0.7× 28 607
Tianbo Jin China 14 163 0.6× 99 0.7× 54 0.5× 15 0.2× 41 0.5× 35 474
Huei‐Tzu Chien Taiwan 14 355 1.3× 246 1.8× 42 0.4× 13 0.2× 79 1.0× 37 711
Dirk Nierhoff Germany 14 446 1.6× 68 0.5× 32 0.3× 38 0.5× 51 0.6× 41 881
Dinç Süren Türkiye 13 129 0.5× 134 1.0× 49 0.4× 16 0.2× 75 0.9× 64 472
Zerai Manna United States 11 141 0.5× 56 0.4× 46 0.4× 13 0.2× 53 0.7× 17 646
Ana P. Lopes Netherlands 14 156 0.6× 68 0.5× 120 1.0× 20 0.2× 24 0.3× 27 500
Valeria Mazzi Italy 14 104 0.4× 98 0.7× 24 0.2× 226 2.7× 29 0.4× 36 446

Countries citing papers authored by Bariş Boyraz

Since Specialization
Citations

This map shows the geographic impact of Bariş Boyraz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bariş Boyraz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bariş Boyraz more than expected).

Fields of papers citing papers by Bariş Boyraz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bariş Boyraz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bariş Boyraz. The network helps show where Bariş Boyraz may publish in the future.

Co-authorship network of co-authors of Bariş Boyraz

This figure shows the co-authorship network connecting the top 25 collaborators of Bariş Boyraz. A scholar is included among the top collaborators of Bariş Boyraz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bariş Boyraz. Bariş Boyraz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Boyraz, Bariş, Claire Crowley, Mansi A. Saksena, et al.. (2025). Papillary Neoplasms of the Breast: WHO Classification, Multimodality Imaging, and Radiologic-Pathologic Correlation. Radiographics. 45(8). e240091–e240091.
3.
Hadi, Kevin, Jiangling Tu, Max F. Levine, et al.. (2024). Enhancing the detection of clinically relevant biomarkers in advanced uterine and tubo-ovarian carcinomas through genome-wide analysis. Pathology - Research and Practice. 266. 155773–155773. 1 indexed citations
4.
Mora, Jesús Delgado-de la, Gunes Gundem, Max F. Levine, et al.. (2024). Whole genome profiling of primary and metastatic adrenocortical carcinoma unravels significant molecular events. Pathology - Research and Practice. 266. 155725–155725. 2 indexed citations
5.
Medford, Arielle J., Lauren Oshry, Bariş Boyraz, et al.. (2023). TRK inhibitor in a patient with metastatic triple-negative breast cancer and NTRK fusions identified via cell-free DNA analysis. Therapeutic Advances in Medical Oncology. 15. 2597580–2597580. 5 indexed citations
6.
Boyraz, Bariş & Amy Ly. (2023). Spectrum of histopathologic findings in risk-reducing bilateral prophylactic mastectomy in patients with and without BRCA mutations. Human Pathology. 151. 105534–105534. 2 indexed citations
7.
Boyraz, Bariş, Ryosuke Tajiri, Arnaud Da Cruz Paula, et al.. (2022). Vulvar angiomyofibroblastoma is molecularly defined by recurrent MTG1‐CYP2E1 fusions. Histopathology. 81(6). 841–846. 2 indexed citations
8.
Boyraz, Bariş, Jaclyn C. Watkins, Robert H. Young, & Esther Oliva. (2022). Uterine Tumors Resembling Ovarian Sex Cord Tumors. The American Journal of Surgical Pathology. 47(2). 234–247. 20 indexed citations
9.
Boyraz, Bariş & Amy Ly. (2022). Discerning subsets of breast cancer with very low and absent HER2 protein expression. Human Pathology. 127. 50–55. 13 indexed citations
10.
Boyraz, Bariş, Kaitlyn E. James, Jason L. Hornick, & Drucilla J. Roberts. (2022). Placental pathology from COVID-19–recovered (nonacute) patients. Human Pathology. 125. 18–22. 12 indexed citations
11.
12.
Hung, Yin P., Aram J. Krauson, Liana Bonanno, et al.. (2021). Factors associated with myocardial SARS-CoV-2 infection, myocarditis, and cardiac inflammation in patients with COVID-19. Modern Pathology. 34(7). 1345–1357. 72 indexed citations
13.
Boyraz, Bariş, Peter M. Sadow, L. Sylvia, et al.. (2021). Cribriform-Morular Thyroid Carcinoma Is a Distinct Thyroid Malignancy of Uncertain Cytogenesis. Endocrine Pathology. 32(3). 327–335. 33 indexed citations
14.
Boyraz, Bariş & Yin P. Hung. (2021). Spindle cell tumors of the pleura and the peritoneum: pathologic diagnosis and updates. Apmis. 130(3). 140–154. 3 indexed citations
15.
Chu, Ying‐Hsia, Dora Dias‐Santagata, Alexander Farahani, et al.. (2020). Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC). Modern Pathology. 33(11). 2186–2197. 78 indexed citations
16.
Sağlam, Arzu, Ece Esin, Mutlu Hayran, Bariş Boyraz, & Ayşegül Üner. (2018). Distribution of lymphomas in Turkey: data of 4239 cases from a single institution using the WHO classification. TURKISH JOURNAL OF MEDICAL SCIENCES. 48(5). 1013–1023. 2 indexed citations
17.
Paulsen, Bruna S., Pankaj Kumar Mandal, Richard L. Frock, et al.. (2017). Ectopic expression of RAD52 and dn53BP1 improves homology-directed repair during CRISPR–Cas9 genome editing. Nature Biomedical Engineering. 1(11). 878–888. 80 indexed citations
18.
Boyraz, Bariş, Eva C. Guinan, Inga Hofmann, et al.. (2015). Mutations in the Poly(A)-Specific Ribonuclease (PARN) Impair Telomerase RNA 3' End Maturation in Dyskeratosis Congenita Patients. Blood. 126(23). 669–669. 1 indexed citations
19.
Boyraz, Bariş, Eva C. Guinan, Inga Hofmann, et al.. (2015). Poly(A)-specific ribonuclease (PARN) mediates 3′-end maturation of the telomerase RNA component. Nature Genetics. 47(12). 1482–1488. 130 indexed citations
20.
Boyraz, Bariş, Mehmet Alı Nahıt Şendur, Sercan Aksoy, et al.. (2013). Trastuzumab emtansine (T-DM1) for HER2-positive breast cancer. Current Medical Research and Opinion. 29(4). 405–414. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. W. Schmid Breakdown of academic impact, for papers by Ana Pestana Breakdown of academic impact, for papers by Yevgeniya Kushchayeva Breakdown of academic impact, for papers by Tianbo Jin Breakdown of academic impact, for papers by Huei‐Tzu Chien Breakdown of academic impact, for papers by Dirk Nierhoff Breakdown of academic impact, for papers by Dinç Süren Breakdown of academic impact, for papers by Zerai Manna Breakdown of academic impact, for papers by Ana P. Lopes Breakdown of academic impact, for papers by Valeria Mazzi
Rankless by CCL
2026